Mycophenolate mofetil Completed Phase 3 Trials for Nephritis, Lupus Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01714817Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis
NCT01042457Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Nephritis
NCT00282347A Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 Class III or IV Lupus Nephritis
NCT00204022Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis.
NCT00377637A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis.